As well as Chinese economy, China’s pharmaceutical market is booming in decades. It is enlarging by more than 20 percent a year and creating attractive opportunities for global pharmaceutical companies at a time. Large multinational companies with powerful R & D capability, numerous capitals and experienced marketing operation enter into Chinese market, which shows a strong influence on domestic pharmaceutical companies. Plus industry regulation reform, pricing restrict, transparent purchasing and fierce competition, the frame of pharmaceutical industry in China is constantly changing. For majority of SME that lack of core competition ability, are facing serious challenges coming from lower revenue per product, high cost of investing capital, and threaten from multinational companies entry.  There must be a scorching transformation including merger, acquisition and even bankruptcy.

How to build core competition, speed up drug development, enhance sale force and improve operation efficiently, which should be highly concerned by every individual pharmaceutical company.

Raise international pharmaceutical team will bring our depth of functional knowledge and breadth of industry experience to help clients including medication manufactures, Retail pharmacies and store, and hospitals to improve their performance by formulating business strategies, choosing retail distribution partners, properly managing distribution channel, build up talent pool and improving operation ability.